Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus

OBJECTIVES: Direct-acting antivirals containing nonstructural protein 5A (NS5A) inhibitors administered over 8 to 12 weeks are effective in ∼95% of patients with hepatitis C virus. Nevertheless, patients resistant to NS5A inhibitors have lower cure rates over 8 weeks (<85%); for these patients, 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Fawsitt, Christopher G., Vickerman, Peter, Cooke, Graham S., Welton, Nicky J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057278/
https://www.ncbi.nlm.nih.gov/pubmed/32113623
http://dx.doi.org/10.1016/j.jval.2019.08.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057278/
https://www.ncbi.nlm.nih.gov/pubmed/32113623
http://dx.doi.org/10.1016/j.jval.2019.08.012

Ejemplares similares